Cargando…

Uncovering a link between COVID-19 and renal cell carcinoma

The cellular action of SARS-CoV-2, the virus responsible for the COVID-19 global pandemic, is dependent on a specific combination of receptors and cofactors. These proteins are now known to be expressed in normal kidney tubule tissue and renal cell carcinoma cells, representing possible targets for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gold, Samuel A., Margulis, Vitaly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	News & Views
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010238/ https://www.ncbi.nlm.nih.gov/pubmed/36914751 http://dx.doi.org/10.1038/s41585-023-00749-8

Ejemplares similares

A deep dive into seagrass Rubisco catalytic properties uncovers a distinct evolutionary trajectory
por: Degen, Gustaf E
Publicado: (2022)

Renal markers for assessment of renal tubular and glomerular dysfunction
por: Spasovski, Dejan
Publicado: (2013)

Tracking COVID-19 with wastewater
por: Larsen, David A., et al.
Publicado: (2020)

Toll‐like receptors matter: plasmacytoid dendritic cells in COVID‐19
por: Becker, Jennifer, et al.
Publicado: (2022)

Targeting the epigenetic addiction of Merkel cell carcinoma
por: Mauri, Federico, et al.
Publicado: (2020)

Counting the neurological cost of COVID-19
por: Baig, Abdul Mannan
Publicado: (2021)

SARS‐CoV‐2 variants as super cell fusers: cause or consequence of COVID‐19 severity?
por: Koch, Jana, et al.
Publicado: (2021)

Can artificial intelligence identify effective COVID‐19 therapies?
por: Schultz, Michael B, et al.
Publicado: (2020)

Autoimmune and inflammatory diseases following COVID-19
por: Galeotti, Caroline, et al.
Publicado: (2020)

Stop wasting protein—Proteasome inhibition to target diseases linked to mitochondrial import
por: Habich, Markus, et al.
Publicado: (2019)

Cryptosporidiosis in renal transplant recipients; concern on effective diagnosis
por: Joob, Beuy, et al.
Publicado: (2015)

CKD is a key risk factor for COVID-19 mortality
por: Gansevoort, Ron T., et al.
Publicado: (2020)

High risk of autoimmune diseases after COVID-19
por: Sharma, Chetan, et al.
Publicado: (2023)

Endovascular stroke treatment during the COVID-19 pandemic
por: Ospel, Johanna M., et al.
Publicado: (2020)

Severe COVID-19 outcomes — the role of physical activity
por: Després, Jean-Pierre
Publicado: (2021)

Collateral cardiovascular damage during the COVID-19 pandemic
por: Nadarajah, Ramesh, et al.
Publicado: (2021)

Amyloid‐β in mitochondrial disease: mutation in a human metallopeptidase links amyloidotic neurodegeneration with mitochondrial processing
por: Boczonadi, Veronika, et al.
Publicado: (2016)

Risk–benefit analysis of COVID-19 vaccines — a neurological perspective
por: Lau, Colleen L., et al.
Publicado: (2021)

Adding the variable of environmental complexity into the COVID‐19 pandemic equation
por: Damialis, Athanasios, et al.
Publicado: (2021)

Glucose-lowering treatments and COVID-19 mortality in T2DM
por: Hadjadj, Samy, et al.
Publicado: (2021)

Individual COVID‐19 disease trajectories revealed by plasma proteomics
por: Memon, Danish, et al.
Publicado: (2021)

Linzhi (Ganoderma lucidum); evidence of its clinical usefulness in renal diseases
por: Joob, Beuy, et al.
Publicado: (2015)

Shiga toxin (Stx) type 2‐induced increase in O‐linked N‐acetyl glucosamine protein modification: a new therapeutic target?
por: Bova, Rebecca A, et al.
Publicado: (2021)

After COVID-19: planning postpandemic care of patients with kidney stones
por: Somani, Bhaskar Kumar
Publicado: (2021)

Brain changes after COVID-19 — how concerned should we be?
por: Kremer, Stéphane, et al.
Publicado: (2022)

The COVID-19 Pandemic has Derailed the Progress of Sustainable Development Goals
por: Priyadarshini, Priya
Publicado: (2022)

Learning in lockdown: Using the COVID‐19 crisis to teach children about food and climate change
por: Kluczkovski, A., et al.
Publicado: (2021)

Safeguarding cancer research funding by European charities amidst the COVID‐19 pandemic
por: Tsagakis, Ioannis, et al.
Publicado: (2020)

Using host receptor as a decoy to treat COVID‐19: a solution for immune escape?
por: Huang, Kuo‐Yen, et al.
Publicado: (2022)

COVID-19 can be called a treatable disease only after we have antivirals
por: Zhang, Xueyang, et al.
Publicado: (2022)

Biochips under COVID-19: a new stage of well-grounded development and accelerated translation
por: Liu, Jiajia, et al.
Publicado: (2022)

Addressing mental health issues amid the COVID-19 pandemic: a wake-up call
por: Gong, Yimiao, et al.
Publicado: (2022)

Pragmatic trials with prespecified subgroups: what oncologists can learn from COVID-19
por: Banerjee, Rahul, et al.
Publicado: (2020)

The “oral” history of COVID‐19: Primary infection, salivary transmission, and post‐acute implications
por: Marchesan, Julie Teresa, et al.
Publicado: (2021)

The riddle of the Sphinx: why sphingosine‐1‐phosphate may help define molecular mechanisms underlying risk stratification for serious COVID‐19 infections
por: Rosen, Hugh, et al.
Publicado: (2020)

Can ACE2 expression explain SARS‐CoV‐2 infection of the respiratory epithelia in COVID‐19?
por: Nawijn, Martijn C, et al.
Publicado: (2020)

Why not use “Twitter” of core clinical journals for rapid dissemination of medical information during the COVID-19 pandemic?
por: Chikazawa, Kenro, et al.
Publicado: (2020)

Perinatal outcomes of pregnant women with severe COVID-19 requiring extracorporeal membrane oxygenation (ECMO): a case series and literature review
por: Clemenza, Sara, et al.
Publicado: (2022)

NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?
por: Gupta, Shilpa, et al.
Publicado: (2020)

Virus ecology: a gap between detection and prediction
por: Drosten, Christian
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kf8caha94s7sq3r7cdh93hoap0